Clinically definite relapsing-remitting multiple sclerosis

Treatment criteria:

• Must be treated by a neurologist.

Clinical criteria:

• The treatment must be the sole PBS-subsidised disease modifying therapy for this condition,

AND

• Patient must be ambulatory (without assistance or support),

AND

• Patient must have experienced at least 2 documented attacks of neurological dysfunction, believed to be due to multiple sclerosis, in the preceding 2 years of commencing a PBS-subsidised disease modifying therapy for this condition,

AND

• The condition must be confirmed by magnetic resonance imaging of the brain and/or spinal cord; OR

• Patient must be deemed unsuitable for magnetic resonance imaging due to the risk of physical (not psychological) injury to the patient.

The date of the magnetic resonance imaging scan must be included in the patient's medical notes, unless written certification is provided, in the patient's medical notes, by a radiologist that an MRI scan is contraindicated because of the risk of physical (not psychological) injury to the patient.

Treatment with this drug must cease if there is continuing progression of disability whilst the patient is being treated with this drug.

For continued treatment the patient must demonstrate compliance with, and an ability to tolerate, this drug.